News Archives
Netgear Login Instructions: Router Web Interface
in News onRead moreThe Netgear switch web interface is the control board for your switch it’s the place every one of the settings…
00Basketball Legends – Play Free Online Games
in News onRead moreB-ball legends diversion is devoted to the enormous begins of b-ball game. You would now be able to play with…
HOW MANY TEETH DO KITTENS HAVE? DO ADULT CATS HAVE MORE?
in News onRead moreWhen we as people are practically nothing, we begin our lives becoming in a lot of little, delightful infant teeth,…
Download TubeMate for PC (Windows 7/8/10 or XP)
in News onRead moreOut of the 400 million downloads, it has been downloaded around 300 million times on Android (download TubeMate APK online…
TUBI TV Has Established Itself As A Leading Free Streaming Service
in News onRead moreIn the realm of gushing, the paid-endorser display is seeing rivalry from allowed to-the-customer promotion upheld choices, for example, Tubi…
Richter announces the acquisition of Finox Holding
in News, Press Releases onRead more30 June 2016 Richter announces the acquisition of Finox Holding for a consideration of CHF190 million. Finox Holding, a…
Allergan and Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
in News, Press Releases onRead moreDUBLIN, Ireland and BUDAPEST, Hungary – 9 May 2016, — Allergan Plc (NYSE: AGN) and Gedeon Richter Plc. today announced positive…
Full Results of PEARL IV Study presented at the European Society of Gynaecological Endoscopy (ESGE) congress confirms the efficacy of ulipristal acetate 5 mg for the long term management of uterine fibroids
in Events, Press Releases onRead moreBudapest, 12 October 2015 – Gedeon Richter Plc. (“Richter”) announces results of the PEARL IV study at ESGE. PEARL IV…
European Commission approves Esmya® 5 mg for intermittent treatment in the long term management of Uterine Fibroids (myomas)
in News, Press Releases onRead moreBudapest, Hungary – 28 May 2015 – Gedeon Richter Plc. (“Richter”) announces that the European Commission (EC) has granted approval…
European Commission approves Esmya® Type II variation, allowing a repeated course of 3-month treatment for uterine fibroids
in News, Press Releases onRead moreBudapest, Hungary, 27 January 2013: Gedeon Richter Plc. (“Richter”) announces that Esmya® 5 mg tablets (ulipristal acetate) is now licensed…
Careers
A career at Preglem® is more than just a job. It gives you the opportunity to solve challenging global problems in a way that can change the world.
Contact us
In line with our corporate culture, we treat all information received with full confidentiality.